Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.
Sáez-Llorens X, Nelson RP Jr, Emmanuel P, Wiznia A, Mitchell C, Church JA, Sleasman J, Van Dyke R, Richardson CG, Cutrell A, Spreen W, Hetherington S. Sáez-Llorens X, et al. Pediatrics. 2001 Jan;107(1):E4. doi: 10.1542/peds.107.1.e4. Pediatrics. 2001. PMID: 11134468 Clinical Trial.
Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant women.
Acosta EP, Zorrilla C, Van Dyke R, Bardeguez A, Smith E, Hughes M, Huang S, Pitt J, Watts H, Mofenson L; Pediatric AIDS Clinical Trials Group 386 Protocol Team. Acosta EP, et al. HIV Clin Trials. 2001 Nov-Dec;2(6):460-5. doi: 10.1310/PUY3-5JWL-FX2B-98VU. HIV Clin Trials. 2001. PMID: 11742433 Clinical Trial.
Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.
Van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K, Morse EV, Krogstad PA, Nachman S; Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team. Van Dyke RB, et al. Pediatrics. 2002 Apr;109(4):e61. doi: 10.1542/peds.109.4.e61. Pediatrics. 2002. PMID: 11927734 Clinical Trial.
Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women.
Acosta EP, Bardeguez A, Zorrilla CD, Van Dyke R, Hughes MD, Huang S, Pompeo L, Stek AM, Pitt J, Watts DH, Smith E, Jiménez E, Mofenson L; Pediatric AIDS Clinical Trials Group 386 Protocol Team,. Acosta EP, et al. Antimicrob Agents Chemother. 2004 Feb;48(2):430-6. doi: 10.1128/AAC.48.2.430-436.2004. Antimicrob Agents Chemother. 2004. PMID: 14742191 Free PMC article. Clinical Trial.
Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants.
Zorrilla CD, Van Dyke R, Bardeguez A, Acosta EP, Smith B, Hughes MD, Huang S, Watts DH, Heckman B, Jiménez E, McSherry G, Mofenson L. Zorrilla CD, et al. Antimicrob Agents Chemother. 2007 Jun;51(6):2208-10. doi: 10.1128/AAC.00871-06. Epub 2007 Apr 9. Antimicrob Agents Chemother. 2007. PMID: 17420209 Free PMC article.
208 results